Genetic factors of obesity
https://doi.org/10.25789/YMJ.2023.82.24
Abstract
The review describes the genetic causes of obesity, including syndromal, monogenic and polygenic causes. The rapidly increasing prevalence of obesity in the population in recent decades is an important public health issue because it increases the risk of diabetes, heart disease, stroke and other serious diseases. Its causes include excessive consumption of high-calorie foods, as well as a sedentary lifestyle. It has been proven that, in addition to energy imbalance, 40–70 % of the development of obesity is influenced by hereditary factors. As a rule, obesity results from the interaction of certain gene polymorphisms with the environment. Only a small number of cases of obesity are the result of the presence of mutations in certain genes (monogenic obesity), causing Mendelian syndromes with a very low frequency in the population.
About the Authors
N. I. PavlovaRussian Federation
Yakutsk
V. A. Alekseev
Russian Federation
Yakutsk
References
1. Association of polymorphism rs9939609 of the FTO gene with the development of obesity in the Yakut population / Pavlova N.I. [et al.] // Modern problems of science and education. 2018. № 5. DOI: 10.17513/spno.28020
2. World Health Organization. Coronavirus disease (COVID-19) pandemic [Electronic resource]. World Health Organization https://www.who.int/europe/emergencies/situations/covid-19
3. Genetic markers of obesity and related reproductive complications: current state of the problem / Artemenko Yu. S. [et al.] // Obstetrics and Gynecology : News. Opinions. Learning. 2021. No. 3 (9). P. 48-55. doi: 10.33029/2303-9698-2021-9-3suppL-48-55
4. Kochetova O.V., Viktorova T.V. Genetics and epigenetics of obesity // Advances in modern biology. 2015. No. 2. P. 128–138.
5. Marinova L.G., Savvina N.V., Savvina I.L. Obesity in children of Yakutia: social and hygienic aspects and clinical characteristics // Yakut medical journal. 2015. No. 3 (51). P. 51-53.
6. Interdisciplinary clinical guidelines "Treatment of obesity and comorbid diseases" / Dedov I.I. [et al.] // Obesity and metabolism. 2021. No. 1 (18). pp.5-99 doi: 10.14341/omet12714
7. Mikhaleva O.G., Bardymova T.P., Berezina M. V. Monogenic forms of obesity // Siberian Medical Journal. 2014. No. 6 (129). pp. 5-11
8. Some molecular genetic mechanisms of the formation of obesity and metabolic syndrome / Lifshits G.I. [et al.] // Pharmacogenetics and pharmacogenomics. 2017. No. 1. pp. 5-9
9. Obesity / Dedov I.I. [et al.] // Consilium Medicum. 2021. No. 4 (23). pp. 311-325 doi: 10.26442/20751753.2021.4.200832.
10. Obesity and breast cancer / Berishvili A.I. [et al.] // Tumors of the female reproductive system. 2022. No. 3(18). pp. 40-51 doi: 10.17650/1994-4098-2022-18-3-40-51
11. Evaluation of overweight and obesity among the indigenous population in the north of Yakutia, depending on ethnicity / Sofronova S.I. [et al.] // Yakut medical journal. 2019. No. 2 (66). pp. 76-79 DOI: 10.25789/YMJ.2019.66.23
12. The role of hyperuricemia in the development of non-alcoholic fatty liver disease / Statsenko M.E. [et al.] // Bulletin of Volgogradsky state medical university. 2022. No. 2 (19). pp. 33-42. doi: 10.19163/1994-9480-2022-19-2-33-42.
13. Sevostyanova E.V. Peculiarities of lipid and carbohydrate metabolism in humans in the North (literature review). // Bulletin of Siberian Medicine. 2013. No. 1 (12). pp. 93-100.
14. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity / Frayling, T.M.; Timpson, N.J.; Weedon, M.N.; Zeggini, E.; Freathy, R.M.; Lindgren, C.M.; Perry, J.R.; Elliott, K.S.; Lango, H.; Rayner, N.W.; et al. // Science. 2007. № 316. Р. 889–894. doi: 10.1126/science.1141634.
15. Association between variants of the leptin receptor gene (LEPR) and overweight: a systematic review and an analysis of the CoLaus study / Bender N, Allemann N, Marek D, Vollenweider P, Waeber G, Mooser V, Egger M, Bochud M. // PLoS One. 2011. 6(10). Р. e26157. DOI: 10.1371/journal.pone.0026157
16. Association of the leptin receptor Q223R (rs1137101) polymorphism with obesity measures in Sri Lankans / Illangasekera YA, Kumarasiri PVR, Fernando DJ, Dalton CF. // BMC Res Notes. 2020.13(1). Р. 34. doi: 10.1186/s13104-020-4898-4.
17. Baier LJ, Bogardus C, Sacchettini JC. A Polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. // J Biol Chem. 1996. 271(18). Р. 10892–10896. DOI: 10.1074/jbc.271.18.10892
18. Bhutani S., Cooper J. A., Vandellen M.R. Self-reported changes in energy balance behaviors during COVID-19 related home confinement: A Cross-Sectional Study // American Journal of Health Behavio. 2021. 45(4). Р. 756-770. DOI: 10.5993/AJHB.45.4.14
19. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α. PPARα fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression / Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G. // Journal of Biological Chemistry. 2001. № 276(34). Рр. 31521–31527. doi: 10.1074/jbc.M103306200.
20. Establishing a genetic link between FTO and VDR gene polymorphisms and obesity in the Emirati population / Khan S.M., Chehadeh S.E.H., Abdulrahman M., Osman W., Al Safar H. // BMC Med. Genet. 2018. №19. Р.11. doi: 10.1186/s12881-018-0522-z.
21. FTO genetic variation and association with obesity in West Africans and African Americans / Adeyemo A, Chen G, Zhou J, Shriner D, Doumatey A, Huang H, Rotimi C.// Diabetes. 2010. 59(6). Р. 1549-54. DOI: 10.2337/db09-1252
22. Genetic and diet effects on Ppar-α and Ppar-γ signaling pathways in the Berlin Fat Mouse Inbred line with genetic predisposition for obesity / Wagener A., Goessling H.F., Schmitt A.O. Mauel S., Gruber A. D., Reinhardt R., Brockmann G. A. // Lipids Health Dis. 2010. № 9. Р. 99 doi: 10.1186/1476-511X-9-99
23. Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits / Scuteri A., Sanna S., Chen W.-M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orrú M., Usala G., et al. // PLoS Genet. 2007. №3. Р. e115. doi: 10.1371/journal.pgen.0030115.
24. Ghrelin and Obesity: Identifying Gaps and Dispelling Myths. A Reappraisal. / Makris MC, Alexandrou A, Papatsoutsos EG, Malietzis G, Tsilimigras DI, Guerron AD, Moris D. // In Vivo. 2017. № 31(6). Рр.1047-1050. doi: 10.21873/invivo.11168.
25. Ghrelin enhances appetite and increases food intake in humans / Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. // J Clin Endocrinol Metab. 2001. № 86(12). Р.5992. doi: 10.1210/jcem.86.12.8111.
26. Implication of genetic variants in overweight and obesity susceptibility among the young Arab population of the United Arab Emirates. / Chehadeh S.E.H., Osman W., Nazar S., Jerman L., Alghafri A., et al. // Gene. 2020. № 739. Р. 144509. DOI: 10.1016/j.gene.2020.144509
27. Incidence and Associated Factors of Weight Gain During the Covid-19 Pandemic. Frontiers in Nutrition. / Daniel M.M., Liboredo J.C., Anastácio L.R., Souza T.C.M., Oliveira L.A., Della Lucia C.M., Ferreira L.G. // Front Nutr. 2022. № 9. Р. 818632. doi: 10.3389/fnut.2022.818632.
28. Interrelation of the FTO rs9939609 SNP and the DAT1 rs27072 SNP with Body Mass Index and Degree of Obesity in the Population of Yakuts / Pavlova N. I., Kurtanov Kh. A., Diakonova A. T., Solovyeva N. A., Sydykova L. Ah., Aleksandrova T. N., Solovyeva Y. A. // International Journal of Biomedicine. 2019. № 9(3). Р. 210-215. DOI: 10.21103/Article9(3)_OA4
29. Lauterbach M.A.R., Wunderlich F.T. Macrophage function in obesity-induced inflammation and insulin resistance // Pflugers Arch. Eur. J. Physiol. 2017. № 469. pp. 385-396 doi: 10.1007/s00424-017-1955-5.
30. Mandard S, Müller M, Kersten S. Peroxisome proliferator-activated receptor α target genes // Cellular and Molecular Life Sciences. 2004. № 61(4). Рр.393–416. doi: 10.1007/s00018-003-3216-3.
31. Mechanistic insight into PPARc and Tregs in atherosclerotic immune inflammation. / Gao Z., Xu X., Li Y., Sun K., Yang M., Zhang Q., Wang S., Lin Y., Lou L., Wu A., Liu W., Nie B. // Front. Pharmacol. 2021. № 12. Article 750078. doi: 10.3389/fphar.2021.750078.
32. Meta-analysis identifies common variants associated with body mass index in east Asians / Wen W., Cho Y.-S., Zheng W., Dorajoo R., Kato N., Qi L., Chen C.-H., Delahanty R.J., Okada Y. // Nat. Genet. 2012. №44. Р. 307–311 doi: 10.1038/ng.1087.
33. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity / Wang Y-X, Lee C-H, Tiep S, et al. // Cell. 2003. № 113(2). Р. 159–170. doi: 10.1016/s0092-8674(03)00269-1.
34. Postprandial Hypertriglyceridemia Is Associated with the Variant 54 Threonine FABP2 Gene / Garcés Da Silva MF, Guarin YA, Carrero Y, Stekman H, Núñez Bello ML, Hernández C, Apitz R, Fernández-Mestre M, Camejo G. // Journal of Cardiovascular Development and Disease. 2018. 5(3). Р.47. doi: 10.3390/jcdd5030047.
35. PPARα Gene Is Involved in Body Composition Variation in Response to an Aerobic Training Program in Overweight/Obese / Cardoso G. A., Ribeiro M. D., Sousa B. R. V., de Oliveira Y., Sena K.F., Batista J.R. E., Almeida A.E. M., Filho J.M.,. Silva R. S. B, Persuhn D.C., Silva A. S. // PPAR Research. 2021. Article ID 8880042. Р. 9. doi: 10.1155/2021/8880042
36. PPARG expression patterns and correlations in obesity / Darwish N. M., Gouda W., Almutairi S.M., Elshikh M.S., Morcos G.N.B. // Journal of King Saud University – Science. 2022. 34 (6). Р. 102116
37. PPARs, Obesity, and Inflammation / Stienstra R, Duval C, Müller M, Kersten S. // PPAR Res. 2007. № 2007. Р. 95974. doi: 10.1155/2007/95974.
38. PPARS: transcription factors controlling lipid and lipoprotein metabolism. / Bocher V, Pineda-Torra I, Fruchart J-C, Staels B. // Annals of the New York Academy of Sciences. 2002. № 967. Р.7–18. DOI: 10.1111/j.1749-6632.2002.tb04258.x
39. Regulation of muscle fiber type and running endurance by PPARδ / Wang Y-X, Zhang C-L, Yu RT, et al. // PLoS Biology. 2004. № 2(10). Р. e294. doi: 10.1371/journal.pbio.0020294
40. Schoeller D.A. The effect of holiday weight gain on body weight // Physiol Behav. 2014. № 134. Р. 66–69. doi: 10.1016/j.physbeh.2014.03.018.
41. Shawky R.M., Sadik D.I. Genetics of obesity // Egyptian Journal of Medical Human Genetics. 2012. № 13(1). P. 11-17 doi: 10.1016/j.ejmhg.2011.08.005
42. Singh R.K., Kumar P., Mahalingam K.Molecular genetics of human obesity : A comprehensive review. // Comptes Rendus Biologies. 2017. № 340 (2). P.87-108. doi: 10.1016/j.crvi.2016.11.007.
43. Smith SA. Peroxisomal proliferate-activated receptors and the regulation of lipid oxidation and adipogenesis // Biochemical Society Transactions. 1997. № 25(4). Р.1242–1248. doi: 10.1042/bst0251242.
44. Switala K, Leonska-Duniec A. Physical activity and gene association with human obesity // Balt J Health Phys Act. 2021. № 13(4). Р. 99-111. doi: 10.29359/BJHPA.13.4.10
45. The genetics of childhood obesity and interaction with dietary macronutrients / Garver W.S., Newman S.B., Gonzales-Pacheco D.M. et al. // Genes Nutr. 2013. № 8. Р. 271–287. doi: 10.1007/s12263-013-0339-5.
46. The FTO Gene Is Associated with Adulthood Obesity in the Mexican Population / Villalobos-Comparán M., Flores-Dorantes M.T., Molina T.V., Rodríguez-Cruz M., Ulloa A.C.G., Robles L., Huertas-Vázquez A., Saucedo-Villarreal N., López-Alarcón M., Sánchez-Muñoz F., et al. // Obesity. 2008. № 16. Р. 2296–2301. doi: 10.1038/oby.2008.367.
47. Tirthani E, Said MS, Rehman A. Genetics and Obesity. // StatPearls Publishing. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK573068/
48. Variation in FTO contributes to childhood obesity and severe adult obesity / Dina C., Meyre D., Gallina S., Durand E., Körner A., Jacobson P., Carlsson L.M.S., Kiess W., Vatin V., Lecoeur C., et al. // Nat. Genet. 2007. 39(6). Р. 724-6. doi: 10.1038/ng2048.
49. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults / NCD Risk Factor Collaboration (NCD-RisC) // Lancet. 2017. № 390 (10113). Р. 2627-2642. doi: 10.1016/S0140-6736(17)32129-3
50. Yiannakouris N. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability // J Clin Endocrinol Metab. 2010. № 86(9). Р. 4434–9 doi: 10.1210/jcem.86.9.7842.
Review
For citations:
Pavlova N.I., Alekseev V.A. Genetic factors of obesity. Yakut Medical Journal. 2023;(2):102-106. https://doi.org/10.25789/YMJ.2023.82.24